Pa02g0431

Functional evidence

eggNOG

Preferred name: CYP715A1 | Seed ortholog: 337451.A0A3S3MNY8 | COG: S | eggNOG OG: p450@131567|CK-8, p450@2759|Dy-9!, p450@3398|FRA-22

Gene Ontology

GO:0000038 very long-chain fatty acid metabolic process; GO:0001523 retinoid metabolic process; GO:0001676 long-chain fatty acid metabolic process; GO:0001822 kidney development; GO:0001890 placenta development; GO:0002933 lipid hydroxylation; GO:0003091 renal water homeostasis; GO:0003095 pressure natriuresis; GO:0004497 monooxygenase activity; GO:0005504 fatty acid binding; GO:0005515 protein binding; GO:0005575 cellular_component; GO:0006631 fatty acid metabolic process; GO:0006690 icosanoid metabolic process; GO:0006691 leukotriene metabolic process; GO:0006693 prostaglandin metabolic process; GO:0006723 cuticle hydrocarbon biosynthetic process; GO:0006805 xenobiotic metabolic process; GO:0007596 blood coagulation; GO:0007618 mating; GO:0008150 biological_process; GO:0008202 steroid metabolic process; GO:0008217 regulation of blood pressure; GO:0008356 asymmetric cell division; GO:0008391 arachidonate monooxygenase activity; GO:0008392 arachidonate epoxygenase activity; GO:0008395 steroid hydroxylase activity; GO:0008404 arachidonate 14,15-epoxygenase activity; GO:0008405 arachidonate 11,12-epoxygenase activity; GO:0008610 lipid biosynthetic process; GO:0009410 response to xenobiotic stimulus; GO:0009416 response to light stimulus; GO:0009636 response to toxic substance; GO:0009651 response to salt stress; GO:0009725 response to hormone; GO:0009737 response to abscisic acid; GO:0009741 response to brassinosteroid; GO:0009826 unidimensional cell growth; GO:0010268 brassinosteroid homeostasis; GO:0010430 fatty acid omega-oxidation; GO:0016125 sterol metabolic process; GO:0016131 brassinosteroid metabolic process; GO:0016135 saponin biosynthetic process; GO:0016709 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; GO:0016712 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; GO:0018685 alkane 1-monooxygenase activity; GO:0018879 biphenyl metabolic process; GO:0019369 arachidonate metabolic process; GO:0019373 epoxygenase P450 pathway; GO:0019395 fatty acid oxidation; GO:0019748 secondary metabolic process; GO:0019825 oxygen binding; GO:0020037 heme binding; GO:0030703 eggshell formation; GO:0032304 negative regulation of icosanoid secretion; GO:0032305 positive regulation of icosanoid secretion; GO:0033574 response to testosterone; GO:0036101 leukotriene B4 catabolic process; GO:0036102 leukotriene B4 metabolic process; GO:0040038 polar body extrusion after meiotic divisions; GO:0042360 vitamin E metabolic process; GO:0042361 menaquinone catabolic process; GO:0042376 phylloquinone catabolic process; GO:0042377 vitamin K catabolic process; GO:0043651 linoleic acid metabolic process; GO:0046456 icosanoid biosynthetic process; GO:0046513 ceramide biosynthetic process; GO:0048252 lauric acid metabolic process; GO:0048598 embryonic morphogenesis; GO:0050051 leukotriene-B4 20-monooxygenase activity; GO:0050544 arachidonate binding; GO:0050830 defense response to Gram-positive bacterium; GO:0052722 fatty acid in-chain hydroxylase activity; GO:0052869 arachidonate omega-hydroxylase activity; GO:0052871 alpha-tocopherol omega-hydroxylase activity; GO:0055078 sodium ion homeostasis; GO:0060840 artery development; GO:0062189 anandamide 14,15 epoxidase activity; GO:0090411 brassinosteroid binding; GO:0097258 20-hydroxy-leukotriene B4 omega oxidase activity; GO:0097259 20-aldehyde-leukotriene B4 20-monooxygenase activity; GO:0097267 omega-hydroxylase P450 pathway; GO:0102033 long-chain fatty acid omega-hydroxylase activity; GO:0103002 16-hydroxypalmitate dehydrogenase activity; GO:0120250 fatty acid omega-hydroxylase activity; GO:0120319 long-chain fatty acid omega-1 hydroxylase activity; GO:0120503 medium-chain fatty acid omega-1 hydroxylase activity; GO:0140692 very long-chain fatty acid omega-hydroxylase activity; GO:0140981 medium-chain fatty acid omega-hydroxylase activity; GO:0160238 long-chain fatty aldehyde oxidative decarbonylase activity; GO:1900541 fumonisin biosynthetic process; GO:1901363 heterocyclic compound binding; GO:1903604 cytochrome metabolic process; GO:1904681 response to 3-methylcholanthrene; GO:1905344 prostaglandin catabolic process; GO:1905517 macrophage migration; GO:2001302 lipoxin A4 metabolic process; GO:2001304 lipoxin B4 metabolic process

KEGG

EC: ec:1.14.14.1, ec:1.14.14.115, ec:1.14.14.177, ec:1.14.14.78, ec:1.14.14.79, ec:1.14.14.80, ec:1.14.14.94 | KO: K00490, K07425, K07426, K07427, K07428, K07429, K15001, K15007, K15638, K15639, K17687, K17726, K17728, K17729, K17730, K17731, K17873, K17952, K17953, K20660, K21475, K23808, K23809, K24179, K25489, K25490 | Pathway: 00071, 00590, 00830, 00905, 00996, 01100, 01110, 03320, 04270, 04726, 04750 | BRITE: 00001, 00199, 01000